|
1. Chainani-Wu N,
Silverman S Jr., Lozada-Nur F, Mayer P, Watson JJ. Oral lichen planus:
patient profile, disease progression and treatment responses. J Am Dent
Assoc. 2001;132:901-9.
https://doi.org/10.14219/jada.archive.2001.0302
PMid:11480643
|
|
|
|
2. Pindborg JJ,
Reichart PA, Smith CJ, van der Waal I. HIstological typing of cancer and
precancer of the oral mucosa. 2nd ed. World health organization
international histological classification of tumours: Berlin Springer;
1997.
https://doi.org/10.1007/978-3-642-60592-5
PMid:9146862
|
|
|
|
|
3. Ismail SB, Kumar
SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis,
diagnosis, management and malignant transformation. J
Oral Sci. 2007;49:89-106.
https://doi.org/10.2334/josnusd.49.89
PMid:17634721
|
|
|
|
|
4. Sugerman PB,
Savage NW. Oral lichen planus: causes, diagnosis and management. Aust
Dent J. 2002;47:290-7.
https://doi.org/10.1111/j.1834-7819.2002.tb00540.x
|
|
|
|
|
5. Ebrahimi M,
Lundqvist L, Wahlin YB, Nylander E. Mucosal lichen planus, a systemic
disease requiring multidisciplinary care: a cross-sectional clinical review
from a multidisciplinary perspective. J Low Genit Tract Dis.
2012;16:377-80.
https://doi.org/10.1097/LGT.0b013e318247a907
PMid:22622344
|
|
|
|
|
6. Lewis FM,
Bogliatto F. Erosive vulval lichen planus--a diagnosis not to be missed: a
clinical review. Eur J Obstet Gynecol Reprod Biol.
2013;171:214-9.
https://doi.org/10.1016/j.ejogrb.2013.09.038
PMid:24183096
|
|
|
|
|
7. Ebrahimi M,
Wahlin YB, Coates PJ, Wiik A, Roos G, Nylander K. Detection of antibodies
against p63 and p73 isoforms in sera from patients diagnosed with oral
lichen planus. J Oral Pathol Med. 2007;36(2):93-8.
https://doi.org/10.1111/j.1600-0714.2007.00504.x
PMid:17238971
|
|
|
|
|
8. Danielsson K,
Boldrup L, Rentoft M, Coates PJ, Ebrahimi M, Nylander E, et al.
Autoantibodies and decreased expression of the transcription factor ELF-3
together with increased chemokine pathways support an autoimmune phenotype
and altered differentiation in lichen planus located in oral mucosa. J
Eur Acad Dermatol Venereol. 2013;27(:1410-6.
|
|
|
|
|
9. Ebrahimi M,
Boldrup L, Wahlin YB, Coates PJ, Nylander K. Decreased expression of the
p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus.
Oral Oncol. 2008;44:634-8.
https://doi.org/10.1016/j.oraloncology.2007.08.001
PMid:17936670
|
|
|
|
|
10. Braumuller H,
Wieder T, Brenner E, Assmann S, Hahn M, Alkhaled M, et al. T-helper-1-cell
cytokines drive cancer into senescence. Nature. 2013;494:361-5.
https://doi.org/10.1038/nature11824
PMid:23376950
|
|
|
|
|
11. Williams H,
Crawford DH. Epstein-Barr virus: the impact of scientific advances on
clinical practice. Blood. 2006;107:862-9.
https://doi.org/10.1182/blood-2005-07-2702
PMid:16234359
|
|
|
|
|
12. Hall LD, Eminger
LA, Hesterman KS, Heymann WR. Epstein-Barr virus: dermatologic associations
and implications: part I. Mucocutaneous manifestations of Epstein-Barr
virus and nonmalignant disorders. J Am Acad Dermatol.
2015;72:1-19; quiz -20.
|
|
|
|
|
13. Dunmire SK,
Grimm JM, Schmeling DO, Balfour HH, Jr., Hogquist KA. The Incubation Period
of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic
Events. PLoS Pathog. 2015;11:e1005286.
https://doi.org/10.1371/journal.ppat.1005286
PMid:26624012 PMCid:PMC4666617
|
|
|
|
|
14. Luzuriaga K,
Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010;362:1993-2000.
https://doi.org/10.1056/NEJMcp1001116
PMid:20505178
|
|
|
|
|
15. Payeras MR,
Cherubini K, Figueiredo MA, Salum FG. Oral lichen planus: focus on
etiopathogenesis. Arch Oral Biol. 2013;58:1057-69.
https://doi.org/10.1016/j.archoralbio.2013.04.004
PMid:23660124
|
|
|
|
|
16. Raab-Traub N,
Flynn K. The structure of the termini of the Epstein-Barr virus as a marker
of clonal cellular proliferation. Cell. 1986;47:883-9.
https://doi.org/10.1016/0092-8674(86)90803-2
|
|
|
|
|
17. Young LS, Yap
LF, Murray PG. Epstein-Barr virus: more than 50 years old and still
providing surprises. Nat Rev Cancer. 2016;16:789-802.
https://doi.org/10.1038/nrc.2016.92
PMid:27687982
|
|
|
|
|
18. Khan G, Miyashita EM, Yang B, Babcock
GJ, Thorley-Lawson DA. Is
EBV persistence in vivo a model for B cell homeostasis? Immunity.
1996;5:173-9.
https://doi.org/10.1016/S1074-7613(00)80493-8
|
|
|
|
|
19. Clemens MJ. The
small RNAs of Epstein-Barr virus. Mol Biol Rep. 1993;17:81-92.
https://doi.org/10.1007/BF00996215
PMid:8384694
|
|
|
|
|
20. Gulley ML. Molecular diagnosis of
Epstein-Barr virus-related diseases. J Mol Diagn. 2001;3:1-10.
https://doi.org/10.1016/S1525-1578(10)60642-3
|
|
|
|
|
21. Yildirim B,
Senguven B, Demir C. Prevalence of herpes simplex, Epstein Barr and human
papilloma viruses in oral lichen planus. Med Oral Patol
Oral Cir Bucal. 2011;16:e170-4.
https://doi.org/10.4317/medoral.16.e170
PMid:21196875
|
|
|
|
|
22. Sand LP, Jalouli
J, Larsson PA, Hirsch JM. Prevalence of Epstein-Barr virus in oral squamous
cell carcinoma, oral lichen planus, and normal oral mucosa. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod. 2002;93:586-92.
https://doi.org/10.1067/moe.2002.124462
PMid:12075209
|
|
|
|
|
23. Adtani P,
Malathi N. Epstein-Barr virus and its association with rheumatoid arthritis
and oral lichen planus. J Oral Maxillofac Pathol. 2015;19:282-5.
https://doi.org/10.4103/0973-029X.174643
PMid:26980953 PMCid:PMC4774278
|
|
|
|
|
24. Vieira Rda R, Ferreira LL, Biasoli ER,
Bernabe DG, Nunes CM, Miyahara GI. Detection of Epstein-Barr virus in different
sources of materials from patients with oral lichen planus: a case-control
study. J Clin Pathol. 2016;69:358-63.
https://doi.org/10.1136/jclinpath-2015-203325
PMid:26468392
|
|
|
|
|
25. Gilligan K,
Rajadurai P, Resnick L, Raab-Traub N. Epstein-Barr virus small nuclear RNAs
are not expressed in permissively infected cells in AIDS-associated
leukoplakia. Proc Natl Acad Sci U S A. 1990;87:8790-4.
https://doi.org/10.1073/pnas.87.22.8790
PMid:2174165 PMCid:PMC55045
|
|
|
|